Wide Ranks

COLL

Collegium Pharmaceutical, Inc.

30.71

Top Statistics
Market Cap 990 M Forward PE 4.67 Revenue Growth 16.50 %
Current Ratio 0.97 Trailing PE 13.12 Earnings Growth -49.50 %
Profit Margins 14.78 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 4.70 Enterprise / Revenue 2.87 Price To Sales Trailing12 Months 1.65
Profitability
Profit Margins 14.78 % Operating Margins 35.17 %
Balance Sheet
Total Cash 144 M Total Cash Per Share 4.50 Total Debt 874 M
Total Debt To Equity 373.23 Current Ratio 0.97 Book Value Per Share 7.27
All Measures
Short Ratio 1569.00 % Message Board Id finmb_7490189 Fax 781 828 4697
Shares Short Prior Month 6 M Return On Equity 0.4289 City Stoughton
Uuid ce084fc3-381a-311e-a750-8eb7c247886f Previous Close 31.19 First Trade Date Epoch Utc 1 B
Book Value 7.27 Beta 0.9490 Total Debt 874 M
Volume 546413 Price To Book 4.22 Fifty Two Week Low 25.21
Total Cash Per Share 4.50 Total Revenue 599 M Shares Short Previous Month Date 1 B
Target Median Price 41.00 Max Age 86400 Sand P52 Week Change 0.3133
Operating Margins 35.17 % Target Mean Price 42.25 Net Income To Common 88 M
Short Percent Of Float 0.2416 Implied Shares Outstanding 32 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 510100 Average Volume10days 510100
Total Cash 144 M Next Fiscal Year End 1 B Revenue Per Share 18.54
Held Percent Insiders 0.0164 Ebitda Margins 61.05 % Trailing PE 13.12
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 31.19
Target Low Price 37.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 35.28
Open 31.23 Free Cashflow 324 M State MA
Dividend Yield 0.00 % Return On Assets 0.0968 Time Zone Short Name EST
Trailing Eps 2.34 Day Low 30.67 Address1 100 Technology Center Drive
Shares Outstanding 32 M Price Hint 2 Target High Price 50.00
Website https://www.collegiumpharma.com 52 Week Change 0.1982 Average Volume 412537
Earnings Quarterly Growth -54.80 % Forward Eps 6.66 Recommendation Key none
Compensation As Of Epoch Date 1 B Quick Ratio 81.30 % Is_sp_500 False
Regular Market Day High 31.70 Profit Margins 14.78 % Debt To Equity 373.23
Fifty Two Week High 42.29 Day High 31.70 Shares Short 6 M
Regular Market Open 31.23 Industry Key drug-manufacturers-specialty-generic Earnings Growth -49.50 %
Enterprise To Revenue 2.87 Revenue Growth 16.50 % Shares Percent Shares Out 0.1949
Operating Cashflow 193 M Currency USD Time Zone Full Name America/New_York
Market Cap 990 M Is_nasdaq_100 False Zip 02072
Quote Type EQUITY Industry Drug Manufacturers - Specialty & Generic Long Name Collegium Pharmaceutical, Inc.
Regular Market Day Low 30.67 Held Percent Institutions 1.22 Current Price 30.71
Address2 Suite 300 Enterprise To Ebitda 4.70 Financial Currency USD
Current Ratio 0.97 Gross Margins 86.67 % Industry Disp Drug Manufacturers - Specialty & Generic
Number Of Analyst Opinions 4 Country United States Float Shares 29 M
Two Hundred Day Average 35.35 Enterprise Value 1 B Price To Sales Trailing12 Months 1.65
Forward PE 4.67 Regular Market Volume 546413 Ebitda 365 M
Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain.

The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003.

Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.